Prospective study on the incidence and evolution of hepatic veno-occlusive disease in patients who underwent stem cell transplant with prophylactic defibrotide therapy as children
DEC-NET Serial number IT360
Published online08/03/2005 12.39.00
Last updated22/07/2005 14.01.56
Other protocol ID number
Current trial statusPlanned (i.e. not yet recruiting participants)
Major Disease
(ICD9 class)		COMPLICATIONS OF TRANSPLANTED BONE MARROW
Experimental drug
DEFIBROTIDE
GenderBoth
Age (range)

Eligibility criteria

Trial design/methodology
Phase2
Kind of studyEfficacy
Prophylaxis
DesignControlled
Randomised
Principal investigator
NameMaura Faraci
InstitutionIstituto G. Gaslini U.O. Trapianto di Midollo
Postal addressLargo G. Gaslini 5
City16147 Genova Quarto
CountryITALY
Phone++39 0105636405
Fax
E-mailmaurafaraci@ospedale-gaslini.ge.it


International lead principal investigator (for international trials)
NameMaura Faraci
InstitutionIstituto G. Gaslini U.O. Trapianto di Midollo
Postal addressLargo G. Gaslini 5
City16147 Genova Quarto
CountryITALY
Phone++390105636405
Fax
E-mail


Sponsor name
Gentium S.p.A.- Villaguardia (CO) (Industry)
European Bone Marrow Transplantation Group (Scientific organisation)


Participating countries
GERMANY
FRANCE
ISRAEL
NETHERLANDS
UNITED KINGDOM
AUSTRIA
IRELAND
ITALY
SWEDEN
SWITZERLAND

ISRCTN  EudraCT  2004-000592-33